The global testosterone test market recorded a market valuation of USD 100.0 million in 2023 and is expected to expand at a CAGR rate of 6.9% to reach a valuation of USD 208.1 million by 2034. North America is leading the market with a share of about 32.4% within the global market.
The operation of male sexual organs and their regular growth depend on the levels of the hormone testosterone. It regulates sex drive, preserves muscular mass, and aids in sperm production in adult men. Testosterone is also found in females in a very small amount in the ovaries. Also, it is produced by the adrenal glands in both males and females.
In the testosterone test, the blood testosterone levels are measured. Most of the testosterone in the blood is protein-bound. The testosterone that is unattached to a protein is called free testosterone. First, the total testosterone test, which measures both attached and free testosterone, is one of the two primary testosterone assays. The second test solely measures free testosterone, and the free testosterone test can reveal more information about some medical issues. In both men and women, low or excessive testosterone levels can cause health problems.
| Key Attributes | Market Insights |
|---|---|
| Testosterone Test Market Value, 2023 | USD 100.0 million |
| Estimated Market Value 2024 | USD 106.6 million |
| Projected Market Value 2034 | USD 208.1 million |
| CAGR (2024 to 2034) | 6.9% |
| Market Share of Top 5 Countries | 58.5% |
| Key Market Players | Medical EXPO, Abbexa, Imaware, LetsGetChecked, Everlywell, Boditech, myLAB Box, Verisana, Ro, Cerascreen, MediChecks, Genway Biotech, Hone Health, Humankind Ventures Ltd., Diagnostic Automation/Cortez Diagnostics Inc., Myclinic.ie, Healthy Human Labs Ltd., MyBioSource, Bluecrest Wellness and Testochecker |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
In 2023, the market for testosterone tests represented around 22.5% of the total global fertility testing market.
The market for testosterone tests has grown at a CAGR of 5.1% from 2019 to 2023, driven by an increase in demand due to rising rates of infertility, erectile dysfunction, testicular cancer, and delayed puberty.
| Historical Market Value, 2023 | USD 100.0 million |
|---|---|
| HCAGR, 2019 to 2033 | 5.1% |
The testosterone tests are performed using blood, saliva, and urine. The testing kits are not only used for testosterone but are now developed by combining several other hormone tests. Thus, advancements in the kit made it possible to diagnose the disease with one kit. Also, the results obtained are much easier to read and understand. The customization of the results based on age is also provided by the companies. The samples taken are pain-free and are easy to collect.
Few of the companies provide video instructions for every step to be performed, which make it easy for the patients to use and they are also provided with live support access. Also, the patients are provided with personalized medical advice with results.
The improper balance of testosterone levels in the body can lead to testicular cancer. Also in females, high levels of testosterone are proven to be the reason for developing conditions like polycystic ovarian syndrome (PCOS). The rising number of PCOS in females has also added to the growth of the testosterone test market.
Hence, owing to the factors mentioned above, the global testosterone test market is projected to grow at a CAGR of 6.9% from 2023 to 2033.
There is a growing awareness regarding the importance of testosterone levels in various health conditions, including hypogonadism, infertility, and sexual dysfunction. This awareness has led to an increased demand for testosterone testing, driving market growth.
Male infertility is a significant concern worldwide, and testosterone testing is an essential component of the diagnostic process. With the increasing prevalence of male infertility, the demand for testosterone tests is expected to rise, presenting growth prospects for the market. Also, several other factors like testicular cancer, delayed puberty, increasing infertility, and low testosterone levels are expected to drive the demand for testosterone test kits over the forecast period.
The testosterone test market has significant growth potential in emerging and developing economies. Factors such as increasing healthcare expenditure, improving healthcare infrastructure, and rising awareness about hormonal disorders contribute to the market's expansion in these regions.
Principal Consultant
The unawareness among the population regarding the availability of these test kits and also, the lack of knowledge about using the kits is a key factor that affects the growth of the market.
Testosterone tests can be expensive, especially when advanced technologies and specialized equipment are involved. The cost factor can limit access to testing for individuals with limited financial resources, impacting market growth. The cost of kits used for testosterone tests is comparatively higher than the laboratory testing. This makes it unconventional to use in developing and underdeveloped countries.
Testosterone tests are performed with blood or saliva. The tests using saliva as the sample in the test kit are still questioned regarding the accuracy of the results. The market's growth throughout the forecast period may be impacted by all of the above-mentioned variables.
| Countries | CAGR (2024 to 2034) |
|---|---|
| United States | 6.4% |
| Germany | 3.9% |
| India | 7.0% |
| United Kingdom | 6.7% |
Accounting for a market share of 89.9%, the United States is leading the market in North America.
Infertility is a key concern and a common problem in males. Infertility in males is rising in the United States. Infertility issues in men are increasing this market in this region.
Testosterone imbalances, such as hypogonadism, are becoming more prevalent in the United States population. Factors such as sedentary lifestyles, obesity, stress, and aging contribute to the rising incidence of these conditions. The need for diagnosing and monitoring testosterone levels drives the demand for testosterone tests.
The Indian market for testosterone tests hold a share of 50.0% of the South Asian market.
Erectile dysfunction is a common complication observed in India. Erectile dysfunction is observed to be common among type 2 diabetes patients. Also, other factors are adding to the erectile dysfunction in males. Thus, it is expected to increase the market for testosterone tests.
The United Kingdom is expected to rise at a CAGR of 6.7% over the forecast period.
Low levels of testosterone cause testicular cancer, increasing the demand for testosterone testing in the country. Similar to other developed countries, the United Kingdom is witnessing a rise in the prevalence of testosterone-related disorders such as hypogonadism.
Lifestyle factors, the aging population, and other health conditions contribute to the increased incidence of testosterone imbalances. This drives the demand for testosterone tests for diagnosis and monitoring.
Germany held a significant share of 27.1% of the Europe testosterone test market.
The increasing healthcare expenditure and the rise in disposable income are the main reasons for boosting the market growth of testosterone tests in Germany. Other than this, the rise in awareness about the importance of testosterone for overall health and well-being is also fuelling market growth. This has led to an increased demand for testosterone tests among men of all age groups.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
The blood sample for testosterone tests had a prominent market share of 45.2% in 2024. The segment is anticipated to grow at a CAGR of 7.0% during the forecast period.
| Top Sample Type | Blood Sample |
|---|---|
| Market Share in 2024 | 45.2% |
Blood samples are commonly used samples for testing any kind of hormone. The blood samples are considered to give accurate results as compared to any other samples. The reliability of the results makes it the most used and preferred sample for testosterone testing.
Males are the ones who are undergoing testosterone tests in a large number accounting for 84.5% market share.
| Top Gender | Males |
|---|---|
| Market Share in 2024 | 84.5% |
Testosterone plays an important role in males. The deficiency or rise in the levels of testosterone causes many problems in males which makes it necessary to have a record of the testosterone levels. As males are mostly affected by the levels of testosterone, therefore they hold a significant market share of this market.
| Top End-use Sector | Home Care Settings |
|---|---|
| Market Share in 2024 | 40.2% |
The home care settings segment accounted for a prominent market share of 40.2%.
The increasing availability of test kits for home care settings and the ease of collecting the sample also the easy availability of the results provided by the manufacturers is boosting the market for home care settings.
To gain a presence in the market, the leading testosterone test businesses are primarily focusing on increasing their market share and kit supply. Leading producers like LetsGetChecked and Everlywell employ tactical strategies like collaboration and expansion to increase the supply of testosterone test kits.
| Attribute | Details |
|---|---|
| Forecast Period | 2024 to 2034 |
| Historical Data Available for | 2019 to 2033 |
| Market Analysis | USD Million for Value |
| Key Regions Covered | North America; Latin America; Europe; South Asia; East Asia; Oceania; and Middle East & Africa (MEA) |
| Key Countries Covered | USA, Canada, Brazil, Mexico, Argentina, UK, Germany, Italy, Russia, Spain, France, BENELUX, India, Thailand, Indonesia, Malaysia, Japan, China, South Korea, Australia, New Zealand, Türkiye, GCC Countries, South Africa and North Africa |
| Key Market Segments Covered | Sample type, Gender, End User, and Region |
| Key Companies Profiled | Abbexa; Imaware; LetsGetChecked; Everlywell; Boditech; myLAB Box; Verisana; Cerascreen; MediChecks; Genway Biotech; Hone Health; Humankind Ventures Ltd.; Diagnostic Automation/Cortez Diagnostics Inc.; Myclinic.ie; Healthy Human Labs Ltd.; MyBioSource; Bluecrest Wellness; Testochecker |
| Pricing | Available upon Request |
The global testosterone test market is worth USD 100.0 million in 2024 and is set to expand by 6.9% over the next ten years.
The market is expected to reach USD 208.1 million by the end of 2033.
The increasing number of manufacturing kits having a combination of different tests, digitalized reports, and the ease of sample collection are a few key trends in this market.
The United States, Germany, the United Kingdom, India, and China are expected to drive demand for the testosterone test industry.
North America is one of the key markets for testosterone tests, with the U.S. accounting for about 89.9% of the North American market in the year 2022.
Demand for testosterone tests in Europe is expected to register a growth of 7.2% over the next ten years.
1. Executive Summary 2. Market Overview 3. Market Trends & Dynamics 4. Value-Added Insights 5. Market Background 6. Global Market Demand Volume (Units) Analysis 2012 to 2022 and Forecast, 2023 to 2033 7. Global Market - Pricing Analysis 8. Global Market Demand (in Value or Size in USD Million) Analysis 2012 to 2022 and Forecast, 2023 to 2033 9. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Sample Type 9.1. Blood 9.2. Urine 9.3. Saliva 10. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, By Gender 10.1. Male 10.2. Female 11. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by End User 11.1. Hospitals 11.2. IVF Centers 11.3. Home Care settings 11.4. Others 12. Global Market Analysis 2012 to 2022 and Forecast 2023 to 2033, by Region 12.1. North America 12.2. Latin America 12.3. Europe 12.4. South Asia 12.5. East Asia 12.6. Oceania 12.7. Middle East & Africa (MEA) 13. North America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 14. Latin America Market Analysis 2012 to 2022 and Forecast 2023 to 2033 15. Europe Market Analysis 2012 to 2022 and Forecast 2023 to 2033 16. East Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 17. South Asia Market Analysis 2012 to 2022 and Forecast 2023 to 2033 18. Oceania Market Analysis 2012 to 2022 and Forecast 2023 to 2033 19. Middle East & Africa Market Analysis 2012 to 2022 and Forecast 2023 to 2033 20. Market Structure Analysis 21. Competition Analysis 21.1. Abbexa 21.2. Imaware 21.3. LetsGetChecked 21.4. Everlywell 21.5. Boditech 21.6. myLAB Box 21.7. Verisana 21.8. Cerascreen 21.9. MediChecks 21.10. Genway Biotech 21.11. Hone Health 21.12. Humankind Ventures Ltd. 21.13. Diagnostic Automation/Cortez Diagnostics Inc. 21.14. Myclinic.ie 21.15. Healthy Human Labs Ltd. 21.16. MyBioSource 21.17. Bluecrest Wellness 21.18. Testochecker 22. Assumptions and Acronyms Used 23. Research Methodology
Explore Healthcare Insights
View Reports
Testosterone Test Market
